|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu c"
Showing items 781-805 of 881 (36 Page(s) Totally)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2009-09-15 |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2009-05-20 |
Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application
|
Kuo, S;Chen, L;Wu, M;Hsu, C;Lin, C;Hsu, P;Yeh, K;Tzeng, Y;Cheng, A |
| 國家衛生研究院 |
2009-04-24 |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL |
| 國立臺灣大學 |
2009-04 |
Frame Misalignment: Interpreting the Implementation of Information Systems Security Certification in an Organization
|
Hsu, C. |
| 國立臺灣大學 |
2009-03 |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.
|
Lin, ZZ; Hsu, HC; Hsu, CH; Yeh, PY; Huang, CY; Huang, YF; Chen, TJ; Kuo, SH; Hsu, C; Hu, FC; Jeng, YM; Chung, Y; Cheng, AL. |
| 國家衛生研究院 |
2009-02 |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen, YC;Hu, FC;Jeng, YM;Chang, YT;Lin, ZZ;Chang, MC;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2009 |
Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis
|
Hsu, C;Shen, Y;Chen, L;Cheng, C;Hu, F;Cheng, A |
| 高雄醫學大學 |
2009 |
軟珊瑚Nephthea erecta and N. chabrolizp 分離純化的sesquiterpenes and norergosterol
|
鄭旭益;溫世宏;邱素芬;王雙桂;戴昌鳳;杜昌益 ; Cheng SY;Huang YC;Wen ZH;Chiou SF;Wang SK;Hsu C;Dai CF;Duh CY |
| 國立臺灣大學 |
2009 |
Creating Experience Economy in E-Commerce
|
Chang, W.; Yuan, S.T.; Hsu, C. |
| 臺大學術典藏 |
2009 |
Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy
|
Chen P.-J.; Cheng A.-L.; SHU-CHEN WEI; Hsu C. |
| 國家衛生研究院 |
2008-12 |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu, C;Kuo, SH;Hu, FC;Cheng, AL;Shih, JY;Yu, CJ;Lin, CC;Huang, TC;Yang, PC;Yang, CH |
| 國立政治大學 |
2008-12 |
Teachers’ perceptions of the dimensions and implementation of technology leadership of principals in Taiwanese elementary schools
|
Chang, I.;秦夢群;Hsu, C.; Chang, I.;Chin, J.M.;Hsu, C. |
| 元智大學 |
2008-05 |
線上遊戲設計: 分析架構與個案探討
|
邱昭彰; Jen, E F; Hsu, C. |
| 國家衛生研究院 |
2008-03 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Chao, TY; Liu, TW; Cheng, AL; Chen, PJ |
| 國立臺灣大學 |
2008-03 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial.
|
Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ |
| 國立臺灣大學 |
2008-03 |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by international prognostic scoring system, cytogenetic and genetic studies.
|
Huang, TC; Ko, BS; Hsu, C; Chen, CY; Tsay, W; Tang, JL; Huang, SY; Yao, M; Chen, YC; Shen, MC; Wang, CH; Tien, HF |
| 國家衛生研究院 |
2008 |
Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment
|
Hsu, C;Chen, LT;Chao, Y;Fan, HH;Shen, YC;Cheng, AL |
| 臺北醫學大學 |
2008 |
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
|
鄭建睿; Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC |
| 臺大學術典藏 |
2008 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
CHIH-HSIN YANG; Yang P.-C; Cheng A.-L; Lin C.-C; Hsu C.-H; Yu C.-J; Chang Y.-C; Chih-Hsin Yang;Yang P.-C;Cheng A.-L;Lin C.-C;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C |
| 臺大學術典藏 |
2008 |
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers
|
Hsu C.; JIN-YUAN SHIH; Yang C.-H.; Yu C.-J.; Lo Y.; Chen J.-P. |
| 臺大學術典藏 |
2008 |
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
|
Jan I.-S.; Wong J.-M.; Tsao P.-N.; Chang Y.-T.; Chang M.-C.; SHU-CHEN WEI; Tien Y.-W.; Hsu C.; Liang P.-C. |
| 臺大學術典藏 |
2008 |
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
|
Wong J.-M.; Jan I.-S.; PO-NIEN TSAO; Liang P.-C.; Hsu C.; Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W. |
| 臺大學術典藏 |
2008 |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Tien H.-F.; Shen M.-C.; Wang C.-H.; Chen Y.-C.; MING YAO; Huang S.-Y.; Tsay W.; Hsu C.; Chen C.-Y.; Tang J.-L.; Ko B.-S.; Huang T.-C. |
| 臺大學術典藏 |
2008 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Chen P.-J.; Cheng A.-L.; Liu T.-W.; Chao T.-Y.; HWEI-FANG TIEN; Wu H.-B.; Li C.-C.; Liao Y.-M.; Young J.-H.; Chang M.-C.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; Hsu C.; Hsiung C.A. |
| 臺大學術典藏 |
2008 |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Tien H.-F.; Wang C.-H.; Shen M.-C.; Chen Y.-C.; Yao M.; Huang T.-C.; BOR-SHENG KO; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y. |
Showing items 781-805 of 881 (36 Page(s) Totally)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
View [10|25|50] records per page
|
